186 related articles for article (PubMed ID: 2468983)
1. Histopathologic observations on the persistence of Mycobacterium leprae in the skin of multibacillary leprosy patients under chemotherapy.
Wabitsch KR; Meyers WM
Lepr Rev; 1988 Dec; 59(4):341-6. PubMed ID: 2468983
[No Abstract] [Full Text] [Related]
2. Leprosy pseudoimbricata: an unusual presentation of steroid-modified borderline lepromatous leprosy.
Kumar S; Mehta H; Aggarwal D; Chatterjee D; Narang T; Dogra S
Int J Dermatol; 2020 Apr; 59(4):e124-e125. PubMed ID: 31957882
[No Abstract] [Full Text] [Related]
3. The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients.
Roche PW; Britton WJ; Neupane KD; Failbus SS; Cho SN; Theuvenet WJ
Am J Trop Med Hyg; 1991 Jun; 44(6):702-8. PubMed ID: 1858971
[TBL] [Abstract][Full Text] [Related]
4. Two microbiological relapses in a patient with lepromatous leprosy.
Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
[TBL] [Abstract][Full Text] [Related]
5. Incidence of late lepra reaction among multibacillary leprosy patients after MDT.
Vijayakumaran P; Manimozhi N; Jesudasan K
Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):18-22. PubMed ID: 7730714
[TBL] [Abstract][Full Text] [Related]
6. Mycobacteria in nerve trunks of long-term treated leprosy patients.
Pereira JH; Palande DD; Gschmeissner SE
Lepr Rev; 1991 Jun; 62(2):134-42. PubMed ID: 1870375
[TBL] [Abstract][Full Text] [Related]
7. Rate of decline in bacterial index in leprosy; observations after three different chemotherapeutic interventions.
Ganapati R; Pai VV; Shroff HJ; Gandewar K
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):264-6. PubMed ID: 9251604
[No Abstract] [Full Text] [Related]
8. Effect of chemotherapy on viability of Mycobacterium leprae as determined by ATP content, morphological index and FDA-EB fluorescent staining.
Katoch VM; Katoch K; Ramanathan U; Sharma VD; Shivannavar CT; Datta AK; Bharadwaj VP
Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):615-21. PubMed ID: 2476522
[TBL] [Abstract][Full Text] [Related]
9. Borderline Lepromatous Leprosy with Type 1 (Reversal) Reactions in a Chinese Man.
Fu X; Liu H; Zhang F
Am J Trop Med Hyg; 2015 Aug; 93(2):207-209. PubMed ID: 26251526
[No Abstract] [Full Text] [Related]
10. A bacteriological assessment of multibacillary cases in leprosy colonies after 4 1/2 years of multidrug therapy.
Naik SS; Bhanage ND; Sawant KV; Ganapati R
Indian J Lepr; 1988 Jul; 60(3):393-9. PubMed ID: 3058827
[TBL] [Abstract][Full Text] [Related]
11. Borderline lepromatous leprosy in an Italian man.
Massone C; Clapasson A; Nunzi E
Am J Trop Med Hyg; 2013 Feb; 88(2):211. PubMed ID: 23390219
[No Abstract] [Full Text] [Related]
12. Histological resolution and bacterial clearance with pulse ROM therapy in borderline lepromatous leprosy.
Suneetha S; Reddy R
Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):53-4. PubMed ID: 11480321
[No Abstract] [Full Text] [Related]
13. Annular lesions in a 70-year-old Austrian man.
Reiter H; Justich A; Massone C
Am J Dermatopathol; 2011 Dec; 33(8):861-2, 869-70. PubMed ID: 22024575
[No Abstract] [Full Text] [Related]
14. Chronic Nodular Dermatosis: A Quiz.
Cusini M; Ramoni S; Boneschi V; Recalcati S
Acta Derm Venereol; 2018 Feb; 98(2):299-300. PubMed ID: 29057426
[No Abstract] [Full Text] [Related]
15. Case for diagnosis. Infiltrated areas on the trunk.
Góes LDM; Scrignoli JA; Morais P; Talhari C
An Bras Dermatol; 2020; 95(5):652-654. PubMed ID: 32651045
[TBL] [Abstract][Full Text] [Related]
16. Transepidermal elimination of lepromatous granuloma: a mechanism for mass transport of viable bacilli.
Namisato M; Kakuta M; Kawatsu K; Obara A; Izumi S; Ogawa H
Lepr Rev; 1997 Jun; 68(2):167-72. PubMed ID: 9217357
[TBL] [Abstract][Full Text] [Related]
17. Zosteriform multidermatomal nodules and plaques in a case of lepromatous leprosy: an uncommon presentation.
Mathachan SR; Sardana K; Ahuja A; Lavania M; Agrawal D
Trop Doct; 2020 Oct; 50(4):378-380. PubMed ID: 32600120
[TBL] [Abstract][Full Text] [Related]
18. Minocycline in lepromatous leprosy.
Fajardo TT; Villahermosa LG; dela Cruz EC; Abalos RM; Franzblau SG; Walsh GP
Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):8-17. PubMed ID: 7730723
[TBL] [Abstract][Full Text] [Related]
19. Relapses during long-term follow up with drug-susceptible M. leprae among multibacillary leprosy patients treated with multidrug therapy regimens; case reports.
Thomas A; Hari L; Nagarajan M; Prabhakar R
Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):391-4. PubMed ID: 7594922
[TBL] [Abstract][Full Text] [Related]
20. Allocation of patients to paucibacillary or multibacillary drug regimens for the treatment of leprosy--a comparison of methods based mainly on skin smears as opposed to clinical methods--alternative clinical methods for classification of patients.
Becx-Bleumink M
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):292-303. PubMed ID: 2071986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]